Trexquant Investment’s Cartesian Therapeutics RNAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2017
Q4
Sell
-641
Closed -$351K 1229
2017
Q3
$351K Buy
641
+80
+14% +$43.8K 0.09% 405
2017
Q2
$334K Buy
+561
New +$334K 0.09% 409